🎙️High participation in the joint IMPACT EU project & REMODEL project webinar: iPSCs for the translational research on rare diseases 🔬
🔬 We are proud to announce that the webinar “Exploiting iPSCs-based research: How REMODEL & IMPACT contribute to disease modelling” was successfully held today!
The event provided a concrete and practical overview of the use of iPSCs as an advanced tool for modelling rare diseases, combining innovative approaches and applications directly from the two R&D projects.
👩‍🔬 Chiara Villa from Università degli Studi di Milano, representing the REMODEL project, showed how iPSCs are used to study neuromuscular diseases, with practical examples in reconstructing key aspects of the disease, while Martina Calore, from Maastricht University for the IMPACT EU project, illustrated the application of iPSCs in the study of arrhythmogenic cardiomyopathy (ACM), highlighting how these models are able to develop personalised intervention strategies.
đź’ˇ The two presentations highlighted how iPSC-based research is changing how rare diseases are studied, giving us a deeper understanding of disease mechanisms and opening up new possibilities for personalised medicine.
🙏 Many thanks to all the speakers for their inspiring presentations and to our audience for joining us!
Stay tuned for future events, scientific results and developments in the IMPACT EU project!
#iPSC #DiseaseModeling #RareDiseases #NeuromuscularDiseases #ACM #StemCells #TranslationalResearch #PersonalizedMedicine #HorizonEurope #REMODELproject #IMPACTproject #ScientificWebinar
đź”´ Here’s the recording of the webinar:
